MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5336-5347
Author(s):
Qiong Wu, Zhiping Yang, Yongquan Shi and Daiming Fan
Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
1101-1109
Author(s):
Camilla Thuring, Linda Geironson and Kajsa Paulsson
HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
1094-1100
Author(s):
Anna Darabi, Camilla Thuring and Kajsa M. Paulsson
Pharmacological Intervention at CCR1 and CCR5 as an Approach for Cancer: Help or Hindrance
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
1553-1573
Author(s):
Angela Karash, Maria R. Mazzoni and Annette Gilchrist
Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
1574-1589
Author(s):
Won-Tak Choi, Yilei Yang, Yan Xu and Jing An
Mitochondrial Biogenesis: Regulation By Endogenous Gases During Inflammation and Organ Stress
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5653-5662
Author(s):
Hagir B. Suliman and Claude A. Piantadosi
Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
429-429
Author(s):
Yusuf Tutar
MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
486-491
Author(s):
Jorg Ellinger and Stefan C. Muller
Intersection of MicroRNA and Gene Regulatory Networks and their Implication in Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
445-454
Author(s):
Malik Yousef, Hung V. Trinh and Jens Allmer
bHLH Transcription Factors Inhibitors for Cancer Therapy: General Features for In Silico Drug Design
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3227-3243
Author(s):
I.F. Tsigelny, V.L. Kouznetsova, S.C. Pingle and S. Kesari